Influence of alpha lipoic acid on antioxidant status in D-galactosamine-induced hepatic injury

Influence of alpha lipoic acid on antioxidant status in D-galactosamine-induced hepatic injury TS Shanmugarajan Department of Pharmaceutical Biotechnology, Vel’s College of Pharmacy, Chennai, Tamilnadu, India D Sivaraman Department of Pharmaceutical Biotechnology, Vel’s College of Pharmacy, Chennai, Tamilnadu, India I Somasundaram Department of Pharmaceutical Biotechnology, Vel’s College of Pharmacy, Chennai, Tamilnadu, India M Arunsundar Department of Pharmaceutical Biotechnology, Vel’s College of Pharmacy, Chennai, Tamilnadu, India E Krishnakumar Department of Pharmaceutical Biotechnology, Vel’s College of Pharmacy, Chennai, Tamilnadu, India R Balaji Department of Biotechnology, Dr MGR Educational and Research Institute, Chennai, Tamilnadu, India V Ravichandiran Department of Pharmaceutical Biotechnology, Vel’s College of Pharmacy, Chennai, Tamilnadu, India

D-Galactosamine (GalN)-induced liver injury is associated with reactive oxygen species and oxidative stress. In the present study, we evaluated the effect of alpha lipoic acid (ALA) supplementation on acute GalN-induced oxidative liver injury. Hepatotoxicity induced by single intraperitoneal injection of GalN (500 mg/kg body wt) was evident from increase in lipid peroxidation and serum marker enzymes (asparate transaminase, alanine transaminase, alkaline phosphatase, and lactate dehydrogenase). The decreased activities of enzymic antioxidants (superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase) as well as glutathione levels were the salient features observed in GalN-induced hepatotoxicity. Pretreatment with ALA (50 mg/kg body weight for 7 days) significantly precluded these changes and prevents the hepatic injury. Hence, this study clearly exemplified that ALA might be a suitable candidate against GalN-induced cellular abnormalities.
11 01 2008 11 2008 635 642 10.1177/0748233708101215 https://journals.sagepub.com/page/policies/text-and-data-mining-license 10.1177/0748233708101215 https://journals.sagepub.com/doi/10.1177/0748233708101215 https://journals.sagepub.com/doi/pdf/10.1177/0748233708101215 https://journals.sagepub.com/doi/pdf/10.1177/0748233708101215 10.1016/B978-0-12-091302-2.50032-3 Aebi H (1974) Catalase. In: Bergmeyer, HV, (ed), Methods Enzymatic Analysis, vol. 2. New York, Cheime, Weinheim, FRG: Academic press, pp. 674–684. 10.1016/S0378-8741(02)00251-9 10.1016/S0955-2863(99)00079-0 10.1016/S1382-6689(01)00078-3 10.3349/ymj.2004.45.5.776 10.1191/0960327103ht358oa 10.1016/0891-5849(88)90018-4 Singapore Med J Bose KSC 415 48 2007 10.1016/S0076-6879(78)52032-6 Free Rad Biol Med Busamante J 60 24 1998 10.1016/S0014-5793(99)00139-8 J Biol Chem Carlberg I 5475 250 1975 10.1016/S0021-9258(19)41206-4 10.1152/physrev.1979.59.3.527 10.1016/S0278-6915(99)00090-3 10.1016/0065-2571(73)90017-4 10.3109/01480547809034433 10.1006/phrs.2000.0772 Arch Biochem Biophys Ellman GL 214 17 1959 Am J Pathol El-Mofty SK 579 79 1975 10.1089/15209150050194279 10.1016/0748-5514(85)90011-X 10.1089/ars.2006.8.1723 10.1002/biof.5520060303 10.1271/bbb.60097 10.1016/0304-4165(70)90183-2 J Lab Clin Med Hebbel RP 401 107 1986 10.1006/phrs.2000.0730 10.1111/j.1432-1033.1969.tb00677.x 10.1016/0014-4800(68)90042-7 King J (1965a) The dehydrogenases or oxidoreductases-lactate dehydrogenase. In: Van, D, (ed), Clinical Enzymology. London: Nostrand Company limited, pp. 83–93. King J (1965b) The dehydrogenases or oxidoreductases-lactate dehydrogenase. In: Van, D, (ed), Clinical Enzymology. London: Nostrand Company limited, pp. 121–138. King J (1965c) The dehydrogenases or oxidoreductases-lactate dehydrogenase. In: Van, D, (ed), Clinical Enzymology. London, Nostrand Company limited, pp. 191–208. 10.1016/j.toxlet.2005.05.018 Ukr Biokhim Zh Korda MM 72 68 1996 10.1016/0305-0491(93)90121-K 10.1016/0006-291X(76)90747-6 10.1089/ars.2007.9.25 10.1016/S0021-9258(19)52451-6 10.1042/bj1070637 Advanced in Food and Nutrition Research Mukherjee PK 277 2003 10.1016/j.jep.2007.07.004 Iran J Pharmaco Ther Narasimhanaidu K 123 8 2005 10.3109/03602539808996311 10.1016/0891-5849(95)00017-R 10.1001/archderm.1986.01660170031013 10.1177/0091270003258654 10.1016/0005-2760(88)90159-2 10.1016/j.jep.2005.09.025 Indian J Pharmacol Rajesh MG 284 36 2004 Res Commun Chem Pathol Pharmacol Seckin S 117 80 1993 10.1016/0002-9343(91)90281-2 10.1113/expphysiol.1997.sp004024 10.1007/s11010-006-0433-8 10.1016/S0006-2952(02)01420-X 10.1016/j.metabol.2007.01.005 10.1034/j.1600-0420.2003.00040.x Drug Metab Dispos Yuan M 225 19 1991 10.1016/j.cccn.2003.11.003